Literature DB >> 10987698

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group.

L A Mandell1, T J Marrie, R F Grossman, A W Chow, R H Hyland.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10987698     DOI： 10.1086/313959

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  117 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  The pulmonary physician in critical care . 3: critical care management of community acquired pneumonia.

Authors:  S V Baudouin
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

3.  Assessing the quality of clinical practice guidelines.

Authors:  James McCormack; Thomas Perry; Robert Rangno; Casey van Breemen; James M Wright
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

Review 4.  Just the berries. Management of community-acquired pneumonia. Evidence-based update.

Authors:  Meyer Balter
Journal:  Can Fam Physician       Date:  2002-11       Impact factor: 3.275

5.  Utility of blood cultures in the management of adults with community acquired pneumonia discharged from the emergency department.

Authors:  S G Campbell; T J Marrie; R Anstey; S Ackroyd-Stolarz; G Dickinson
Journal:  Emerg Med J       Date:  2003-11       Impact factor: 2.740

6.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

Authors:  W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

7.  Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia.

Authors:  V Erard; O Lamy; P-Y Bochud; J Bille; A Cometta; T Calandra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-15       Impact factor: 3.267

8.  Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.

Authors:  J H Jorgensen; S A Crawford; L M McElmeel; C G Whitney
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

9.  Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies.

Authors:  Kunihiro Inai; Hiromichi Iwasaki; Sakon Noriki; Satoshi Ikegaya; Masanori Yamashita; Yoshiaki Imamura; Nobuo Takimoto; Hisataka Kato; Takanori Ueda; Hironobu Naikia
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

Review 10.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  Nelson Lee; Kwok-Yung Yuen; Cyrus R Kumana
Journal:  Drugs       Date:  2003       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.